At Genmab, we are dedicated to building extra[not]ordinary® futures, together, by developing antibody products and groundbreaking, knock-your-socks-off KYSO antibody medicines® that change lives and the future of cancer treatment and serious diseases. We strive to create, champion and maintain a global workplace where individuals' unique contributions are valued and drive innovative solutions to meet the needs of our patients, care partners, families and employees.
Our people are compassionate, candid, and purposeful, and our business is innovative and rooted in science. We believe that being proudly authentic and determined to be our best is essential to fulfilling our purpose. Yes, our work is incredibly serious and impactful, but we have big ambitions, bring a ton of care to pursuing them, and have a lot of fun while doing so.
Does this inspire you and feel like a fit? Then we would love to have you join us!
Director, Center for Outcomes Research, Real World Evidence and Epidemiology (Global CORE)
This position will be responsible for developing and executing robust health economics, outcomes research, epidemiology and real-world evidence plans for a product/indication in alignment with development, medical affairs, market access and brand strategy. This role requires strong strategic thinking, scientific leadership and cross-functional influence.
Strategy- Define and lead the development/execution of global CORE strategy ensuring alignment with asset strategy, market access needs, and regulatory expectations.
- Co-develop and oversee the Integrated Evidence Generation Plan (IEGP) in partnership with Medical Affairs Strategy and cross-functional stakeholders.
- Co-develop HTA strategy in partnership with market access by generating evidence that clearly articulates unmet need, value differentiation, and outcomes meaningful to access decision makers.
- Inform development and commercialization strategies by integrating real-world, epidemiology, and health economic insights to guide comparator, population, and endpoint selection.
Evidence Generation- Drive strategic planning and prioritization of CORE research programs, including real-world evidence, epidemiology, and health economics and outcomes research, to support:
- Demonstration of product differentiation and value for commercial and market access needs
- Clinical development, regulatory, safety, and lifecycle management objectives
- Ensure generation of high-quality evidence on disease epidemiology, treatment patterns, unmet need, comparative effectiveness, and economic and patient-reported outcomes.
- Lead planning, execution, and governance of the global CORE portfolio, including accountability for timelines, budgets, and resource allocation.
- Ensure all CORE research is conducted with the highest standards of scientific rigor, compliance, and methodological excellence.
Evidence Dissemination- Drive effective dissemination of CORE evidence through dossiers, publications and field-ready scientific content.
Customer Engagement- Serve as a scientific partner to Market Access by supporting early HTA scientific advice.
- Lead external expert engagement, including collaboration with thought leaders, academic partners, and methodological experts to advance evidence generation and credibility.
- Establish, cultivate, and maintain strategic relationships with external vendors and research partners to ensure high-quality and timely execution of CORE activities.
Leadership & Cross-Functional Collaboration- Drive strong cross-functional collaboration across development, commercial, market access, safety, legal, regulatory, and medical affairs teams to optimize the impact of CORE evidence.
- Ensure seamless integration of CORE activities across global, US, EU, and Japan teams.
REQUIREMENTSo Graduate (PhD or Masters) degree and/or relevant work experience in health economics, outcomes research, epidemiology, health services research, public health, health policy
o Minimum requirement: 10+ years in the pharmaceutical industry or a managed care setting in the direct conduct of health economics, outcomes research, real-world evidence, and epidemiology studies
o Extensive experience with outcomes research methods, including study design and analysis
o Demonstrated research accomplishments as evidenced by a history of peer-reviewed publications
o Experience working with HTA process in key markets
o Prior experience in building external connections with peers, regulatory communities across regions, and external network
o Proven performance in earlier role/comparable role including strategic oversight and strategic stakeholder management across levels internally and externally
o Experience directing teams directly/indirectly in a leadership capacity with focus on both achievement of objectives as well as critical skill-building preferred
For US based candidates, the proposed salary band for this position is as follows:
$231,280.00 - $346,920.00
The actual salary offer will carefully consider a wide range of factors, including your skills, qualifications, experience, and location. Also, certain positions are eligible for additional forms of compensation, such as discretionary bonuses and long-term incentives.
When you join Genmab, you're joining a culture that supports your physical, financial, social, and emotional wellness. Within the first year, regular full-time U.S. employees are eligible for:
- 401(k) Plan: 100% match on the first 6% of contributions
- Health Benefits: Two medical plan options (including HDHP with HSA), dental, and vision insurance
- Voluntary Plans: Critical illness, accident, and hospital indemnity insurance
- Time Off: Paid vacation, sick leave, holidays, and 12 weeks of discretionary paid parental leave
- Support Resources: Access to child and adult backup care, family support programs, financial wellness tools, and emotional well-being support
- Additional Perks: Commuter benefits, tuition reimbursement, and a Lifestyle Spending Account for wellness and personal expenses
Further details on eligibility for compensation and benefits based on role will be provided during the recruitment process
About GenmabGenmab is an international biotechnology company with a core purpose to improve the lives of patients through innovative and differentiated antibody therapeutics. For 25 years, its hard-working, innovative and collaborative team has invented next-generation antibody technology platforms and harnessed translational, quantitative and data sciences, resulting in a proprietary pipeline including bispecific T-cell engagers, antibody-drug conjugates, next-generation immune checkpoint modulators and effector function-enhanced antibodies. By 2030, Genmab's vision is to transform the lives of people with cancer and other serious diseases with Knock-Your-Socks-Off (KYSO®) antibody medicines.
Established in 1999, Genmab is headquartered in Copenhagen, Denmark with international presence across North America, Europe and Asia Pacific. For more information, please visit Genmab.com and follow us on
LinkedIn and
X.
Genmab is committed to protecting your personal data and privacy. Please see our privacy policy for handling your data in connection with your application on our website
Job Applicant Privacy Notice (genmab.com).
Please note that if you are applying for a position in the Netherlands, Genmab's policy for all permanently budgeted hires in NL is initially to offer a fixed-term employment contract for a year, if the employee performs well and if the business conditions do not change, renewal for an indefinite term may be considered after the fixed-term employment contract.
